Seres Therapeutics (MCRB) Reports Q3 EPS of $0.72

Seres Therapeutics (NASDAQ: MCRB) reported Q3 EPS of $0.72. Revenue for the quarter came in at $126.7M.

For earnings history and earnings-related data on Seres Therapeutics (MCRB) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• C.H. Robinson acquires DeSpir Logistics for $75 million
• Stifel Reiterates Buy Rating on FedEx (FDX) Ahead of Q4 Earnings